About Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
4
Hoffmann-La Roche
4
Ipsen
3
Chiasma, Inc.
1
Genentech, Inc.
1
LungenClinic Grosshansdorf
1
University Hospital Padova
1
Clinical Trials at Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV
During the past decade, Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients
2003-01-01
Completed
328
A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.
2004-02-01
Terminated
562
Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options
2004-05-01
2006-04-01
Completed
255
Efficacy and Safety Study of Varying Doses of Lanreotide Autogel in Patients With Acromegaly
2000-05-01
2003-01-03
Completed
108
3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study
2002-03-01
Completed
216
Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients
2006-10-01
2008-10-01
Completed
125
A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT)
2007-05-15
2018-05-14
Terminated
836
Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
2006-06-01
Unknown status
260
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials
sponsored, "Ipsen" with 3 trials sponsored, "Chiasma, Inc." with 1 trials sponsored and "Genentech, Inc."
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV"
#1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV
According to Clinical.Site data, the most researched conditions in "Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV" are
"Acromegaly" (4 trials), "HIV Infections" (4 trials), "Rheumatoid Arthritis" (3 trials), "Giant Cell Arteritis" (1 trials) and "Hyperaldosteronism" (1 trials). Many other conditions were trialed in "Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV
Most popular intervention types in "Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV" are "Drug" (14 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Tocilizumab" (4 trials), "Methotrexate" (3 trials), "Placebo" (2 trials), "Prednisone" (2 trials) and "Corticosteroids" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV
The vast majority of trials in "Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV" are
15 trials for "All" genders.
Clinical Trials Status at Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV
Currently, there are NaN active trials in "Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".